Royall
356783-28-3
C23h32f3n5o4
Pharmaceutical Intermediates
Powder
Refined
White
Favipiravir Intermediate
356783-28-3
99%Min
Aluminum Oil Bag
Pharma Grade
Royall
Carton, Drum
25KG/drum
China
Product Description
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm) is established in 2012 at the beautiful West Lake - Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include Antiviral products, Contrast Media, related formulation, intermediates, and new product development.
We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhejiang, Jiangxi, Chengdu and Shandong. We have more than 80 technical staff, the company's management team has experience in R&D, GMP production, analysis, registration, etc. The technical management level is in a leading position in the pharmaceutical industry. We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.
Antivial products include: Redisevir, Hydroxychloroquine Sulfate, Abidol Sulfate, Oseltamivir Phosphate, Ritonavir, Lopinavir, etc. And related preparations and intermediates.
Contrast products: Iohexol, Iopamidol, Iodixanol, Iopromide, Ioversol, Iomepride, Gadopentate meglumine, Gadoterate, etc. And related preparations and intermediates.
We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhejiang, Jiangxi, Chengdu and Shandong. We have more than 80 technical staff, the company's management team has experience in R&D, GMP production, analysis, registration, etc. The technical management level is in a leading position in the pharmaceutical industry. We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.
Antivial products include: Redisevir, Hydroxychloroquine Sulfate, Abidol Sulfate, Oseltamivir Phosphate, Ritonavir, Lopinavir, etc. And related preparations and intermediates.
Contrast products: Iohexol, Iopamidol, Iodixanol, Iopromide, Ioversol, Iomepride, Gadopentate meglumine, Gadoterate, etc. And related preparations and intermediates.
Basic Info
Chemical Name | 3,6-Difluoropyrazine-2-carbonitrile |
Synonyms | QC-769;2-Pyrazinecarbonitrile,3,6-difluoro;3,6-difluoro-2-pyrazinecarbonitrile; |
CAS No. | 356783-28-3 |
Molecular Formula | C5HF2N3 |
Molecular Weight | 141.07800 |
PSA | 49.57000 |
LogP | 0.62648 |
Numbering system
MDL number | MFCD22199270 |
Safety Info
HS Code | 2933990090 |